Nipro Management
Management criteria checks 2/4
Nipro's CEO is Yoshihiko Sano, appointed in May 2012, has a tenure of 12.33 years. directly owns 0.068% of the company’s shares, worth ¥152.33M. The average tenure of the management team and the board of directors is 10.4 years and 15.3 years respectively.
Key information
Yoshihiko Sano
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 12.3yrs |
| CEO ownership | 0.07% |
| Management average tenure | 10.4yrs |
| Board average tenure | 15.3yrs |
Recent management updates
Recent updates
Nipro's (TSE:8086) Dividend Will Be ¥12.00
Aug 30
Nipro (TSE:8086) Has Announced A Dividend Of ¥12.00
Jul 25Nipro (TSE:8086) Will Pay A Dividend Of ¥12.00
Jul 11Nipro (TSE:8086) Has A Somewhat Strained Balance Sheet
Jun 06Earnings Tell The Story For Nipro Corporation (TSE:8086)
Apr 02Nipro (TSE:8086) Will Pay A Larger Dividend Than Last Year At ¥15.00
Feb 27CEO
Yoshihiko Sano (79 yo)
12.3yrs
Tenure
Mr. Yoshihiko Sano serves as President since May 2012 and Representative Director of Nipro Corporation. Mr. Sano served as Managing Director of Nipro Corporation since June 2006 until May 2012. He is Chair...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of Board & President | 12.3yrs | no data | 0.068% ¥ 152.3m | |
| Manager of Accounting Department - Corporate Planning Division | 10.2yrs | no data | no data | |
| GM of General Affairs | 10.2yrs | no data | 0.015% ¥ 34.6m | |
| Senior MD | 12.3yrs | no data | 0.0061% ¥ 13.7m | |
| MD, Head of Planning and Development and Director | 9.3yrs | no data | 0.0084% ¥ 18.9m | |
| Senior MD | 9.7yrs | no data | 0.011% ¥ 25.1m | |
| MD, Head of Regenerative Medicine and Business Promotion | 9.3yrs | no data | 0.018% ¥ 40.3m | |
| MD, GM of Facilities Division & Production Technology Center and Director | 10.4yrs | no data | 0.011% ¥ 24.3m | |
| MD, Head of Pharmaceutical Business Division and Pharmaceutical Production & Director | 11.9yrs | no data | 0.0037% ¥ 8.4m | |
| MD, GM of the Stable Production & Crisis Management Division and Director | 10.4yrs | no data | 0.013% ¥ 28.1m | |
| Director of Quality Assurance Division & Director | 13.4yrs | no data | 0.0094% ¥ 21.1m | |
| MD, Head of Vascular Business Division & Director | no data | no data | 0.012% ¥ 27.3m |
10.4yrs
Average Tenure
66yo
Average Age
Experienced Management: 8086's management team is seasoned and experienced (10.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of Board & President | 31.6yrs | no data | 0.068% ¥ 152.3m | |
| GM of General Affairs | 15.3yrs | no data | 0.015% ¥ 34.6m | |
| Senior MD | 18.3yrs | no data | 0.0061% ¥ 13.7m | |
| MD, Head of Planning and Development and Director | no data | no data | 0.0084% ¥ 18.9m | |
| Senior MD | no data | no data | 0.011% ¥ 25.1m | |
| MD, Head of Regenerative Medicine and Business Promotion | 15.3yrs | no data | 0.018% ¥ 40.3m | |
| MD, GM of Facilities Division & Production Technology Center and Director | 14.3yrs | no data | 0.011% ¥ 24.3m | |
| MD, Head of Pharmaceutical Business Division and Pharmaceutical Production & Director | no data | no data | 0.0037% ¥ 8.4m | |
| MD, GM of the Stable Production & Crisis Management Division and Director | no data | no data | 0.013% ¥ 28.1m | |
| Director of Quality Assurance Division & Director | 14.3yrs | no data | 0.0094% ¥ 21.1m | |
| MD, Head of Vascular Business Division & Director | no data | no data | 0.012% ¥ 27.3m | |
| Senior MD | 18yrs | no data | 0.0043% ¥ 9.7m |
15.3yrs
Average Tenure
64yo
Average Age
Experienced Board: 8086's board of directors are seasoned and experienced ( 15.3 years average tenure).